Hip prosthesis

New research may pave the way for all-metal hip prostheses to rise phoenix-like from the ashes.

A new article in the New York times suggests J&J DePuy were wrong in continuing to sell product overseas after FDA raised concerns. If that happened every time FDA demanded more clinicals we might as well harmonise.

After being available for over ten years internationally, Smith & Nephew finally introduced its POLARCUP Dual Mobility Hip System to orthopaedic surgeons in the US.

Update from TeDan surgical on CE status of its new MIS Hip Retractor.

A new retractor makes MIS anterior hip procedures easier.

Exactech’s marketing communications doing a good job of attracting you to their AAOS booth by explaining what you’ll find when you get there.

Following another media flare-up in the ongoing metal-on-metal discussion, NHS has followed UK competent authority the MHRA into releasing a positioning document of its own.

UK MHRA updates all-metal hip guidance with statement that most patients are at low risk of developing any serious problems.

FDA warns DePuy about the use of custom device exemption to allegedly supply devices that don’t fit FDA’s definition of custom. DePuy then ceases manufacturing all custom devices.

After studying data relating to 3404 hips enrolled in 18 comparative studies and over 830 000 operations in national registries, researchers showed only limited evidence of comparative effectiveness of various hip implant bearing combinations.

Many large American companies consider the Far East to represent the best chance for growth, while paradoxically Chinese manufacturers are looking at USA as an opportunity to increase their own revenues.

Northwestern University has issued a press release about recent work published in December in Science relating to the formation of graphitic carbon, which has been identified as a naturally forming lubricant in metal-on-metal bearing surfaces in hip prostheses.

Clinical concerns about Hip Resurfacing will negatively affect growth in the Hip segment, according to a new Millennium Research Group report.

US sales down, International Sales well up for the quarter as Exactech sees overall sales revenue growth for the quarter of 13% year on year.

Stryker has announced its intention to implement focused workforce reductions of approximately 5% of its global workforce and other restructuring activities that are anticipated to reduce annual pre-tax operating costs by over $100 million beginning in 2013.

The Annual French Orthopaedic and Traumatology Society (SOFCOT) Congress and takes place next week at the Palais des Congrès in Paris.